Therapy for Early COVID-19 A Critical Need

被引：92

作者：

Kim, Peter S. ^{[1
]}

Read, Sarah W. ^{[1
]}

Fauci, Anthony S. ^{[2
]}

机构：

[1] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA

[2] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2020年 / 324卷 / 21期

关键词：

D O I：

10.1001/jama.2020.22813

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this Viewpoint, Fauci and NIAID colleagues review leading candidates for treatment of mild to moderate coronavirus disease 2019 (COVID-19) to prevent disease progression and longer-term complications, including emerging antiviral drugs, immune-modulating agents, and antibody-based therapies, and the challenges of developing randomized trials to rapidly evaluate the safety and efficacy of each.

引用

页码：2149 / 2150

页数：2

共 7 条

[1] Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial [J].

Abella, Benjamin S. ;

Jolkovsky, Eliana L. ;

Biney, Barbara T. ;

Uspal, Julie E. ;

Hyman, Matthew C. ;

Frank, Ian ;

Hensley, Scott E. ;

Gill, Saar ;

Vogl, Dan T. ;

Maillard, Ivan ;

Babushok, Daria, V ;

Huang, Alexander C. ;

Nasta, Sunita D. ;

Walsh, Jennifer C. ;

Wiletyo, E. Paul ;

Gimotty, Phyllis A. ;

Milone, Michael C. ;

Amaravadi, Ravi K. .

JAMA INTERNAL MEDICINE, 2021, 181 (02) :195-202

[2]

Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI [10.1056/NEJMc2022236, 10.1056/NEJMoa2007764]

[3] SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 [J].

Chen, Peter ;

Nirula, Ajay ;

Heller, Barry ;

Gottlieb, Robert L. ;

Boscia, Joseph ;

Morris, Jason ;

Huhn, Gregory ;

Cardona, Jose ;

Mocherla, Bharat ;

Stosor, Valentina ;

Shawa, Imad ;

Adams, Andrew C. ;

Van Naarden, Jacob ;

Custer, Kenneth L. ;

Shen, Lei ;

Durante, Michael ;

Oakley, Gerard ;

Schade, Andrew E. ;

Sabo, Janelle ;

Patel, Dipak R. ;

Klekotka, Paul ;

Skovronsky, Daniel M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03) :229-237

[4] Long-term Health Consequences of COVID-19 [J].

del Rio, Carlos ;

Collins, Lauren F. ;

Malani, Preeti .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (17) :1723-1724

[5]

Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]

[6] Corticosteroids in COVID-19 ARDS Evidence and Hope During the Pandemic [J].

Prescott, Hallie C. ;

Rice, Todd W. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (13) :1292-1295

[7] Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis [J].

Sterne, Jonathan A. C. ;

Murthy, Srinivas ;

Diaz, Janet, V ;

Slutsky, Arthur S. ;

Villar, Jesus ;

Angus, Derek C. ;

Annane, Djillali ;

Pontes Azevedo, Luciano Cesar ;

Berwanger, Otavio ;

Cavalcanti, Alexandre B. ;

Dequin, Pierre-Francois ;

Du, Bin ;

Emberson, Jonathan ;

Fisher, David ;

Giraudeau, Bruno ;

Gordon, Anthony C. ;

Granholm, Anders ;

Green, Cameron ;

Haynes, Richard ;

Heming, Nicholas ;

Higgins, Julian P. T. ;

Horby, Peter ;

Juni, Peter ;

Landray, Martin J. ;

Le Gouge, Amelie ;

Leclerc, Marie ;

Lim, Wei Shen ;

Machado, Flavia R. ;

McArthur, Colin ;

Meziani, Ferhat ;

Moller, Morten Hylander ;

Perner, Anders ;

Petersen, Marie Warrer ;

Savovic, Jelena ;

Tomazini, Bruno ;

Veiga, Viviane C. ;

Webb, Steve ;

Marshall, John C. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (13) :1330-1341

← 1 →